Processa Pharmaceuticals, Inc. (PCSA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.94M | 5.67M | 6.59M | 7.15M | 3.76M | 1.87M | 4.84M | 7.48M | 9.8M | 5.63M | 7.91M | 9.9M |
| Cash & Short-Term Investments | 1.69M | 5.54M | 6.31M | 6.94M | 2.9M | 1.19M | 2.89M | 5.57M | 8.92M | 4.71M | 6.86M | 8.68M |
| Cash Only | 1.69M | 5.54M | 6.31M | 6.94M | 2.9M | 1.19M | 2.89M | 5.57M | 8.92M | 4.71M | 6.86M | 8.68M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 247.36K | 133.92K | 0 | 29K | 0 | 0 | 0 | 0 | 22.3K | 926.3K | 0 | 0 |
| Total Non-Current Assets | 2.58M | 2.14M | 997.81K | 1.03M | 1.05M | 1.36M | 104.01K | 123K | 144.44K | 154.15K | 175.26K | 193.14K |
| Property, Plant & Equipment | 0 | 0 | 4.11K | 28.73K | 52.45K | 75.69K | 98.48K | 117.47K | 138.9K | 148.61K | 169.73K | 187.6K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.59M | 1.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 997.21K | 997.51K | 993.7K | 999.24K | 999.24K | 1.28M | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K |
| Total Assets | 4.52M | 7.81M | 7.58M | 8.18M | 4.81M | 3.23M | 4.94M | 7.6M | 9.94M | 5.79M | 8.08M | 10.09M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -6% | 141.96% | 53.47% | 7.64% | -51.64% | -44.19% | -38.86% | -24.67% | -20.01% | -32.87% | -56.55% | -53.41% |
| Total Current Liabilities | 1.98M | 2.24M | 1.75M | 2.07M | 1.28M | 1.53M | 1.22M | 1.55M | 1.01M | 730.58K | 826.07K | 821.41K |
| Accounts Payable | 840.37K | 1.06M | 727.17K | 785.75K | 552.56K | 880.88K | 711.71K | 953.09K | 455.37K | 311.62K | 346.3K | 239.02K |
| Days Payables Outstanding | 283.63K | - | - | - | - | 243.39K | - | - | - | 216.17K | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 189.04K | 194.79K | 189K |
| Current Ratio | 0.98x | 2.54x | 3.76x | 3.45x | 2.93x | 1.22x | 3.97x | 4.82x | 9.70x | 7.71x | 9.57x | 12.05x |
| Quick Ratio | 0.98x | 2.54x | 3.76x | 3.45x | 2.93x | 1.22x | 3.97x | 4.82x | 9.70x | 7.71x | 9.57x | 12.05x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 487 | 2.17K | 25.65K | 50.7K | 66.91K | 88.78K | 109.33K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 487 | 2.17K | 25.65K | 50.7K | 66.91K | 88.78K | 109.33K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.98M | 2.24M | 1.75M | 2.07M | 1.28M | 1.53M | 1.22M | 1.58M | 1.06M | 797.48K | 914.85K | 930.74K |
| Total Debt | 0 | 0 | 0 | 25.58K | 49.66K | 73.51K | 96.84K | 118.83K | 140.38K | 150.55K | 171.52K | 191.22K |
| Net Debt | -1.69M | -5.54M | -6.31M | -6.91M | -2.85M | -1.12M | -2.79M | -5.45M | -8.78M | -4.56M | -6.69M | -8.49M |
| Debt / Equity | - | - | - | 0.00x | 0.01x | 0.04x | 0.03x | 0.02x | 0.02x | 0.03x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 2.54M | 5.58M | 5.83M | 6.11M | 3.53M | 1.7M | 3.72M | 6.02M | 8.88M | 4.99M | 7.17M | 9.16M |
| Equity Growth % | -27.95% | 228.82% | 56.78% | 1.39% | -60.3% | -66% | -48.09% | -34.24% | -12.41% | -33.22% | -58.42% | -54.39% |
| Book Value per Share | 0.97 | 2.17 | 3.07 | 9.81 | 9.25 | 11.47 | 28.39 | 50.48 | 90.04 | 96.99 | 132.72 | 170.03 |
| Total Shareholders' Equity | 2.54M | 5.58M | 5.83M | 6.11M | 3.53M | 1.7M | 3.72M | 6.02M | 8.88M | 4.99M | 7.17M | 9.16M |
| Common Stock | 269 | 257 | 5.29K | 4.03K | 527 | 371 | 327 | 287 | 286 | 129 | 2.47K | 2.46K |
| Retained Earnings | -104.16M | -100.78M | -97.42M | -93.99M | -90.05M | -87.22M | -84.49M | -81.11M | -78.1M | -75.37M | -72.96M | -70.88M |
| Treasury Stock | 0 | -300K | -300K | -300K | -300K | -300K | -300K | -300K | -300K | -300K | -300K | -300K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |